B&K CORP-B (02396) recommends the Caina Technology Incentive Plan.
Qingcheng New Medicine-B (02396) announced that on August 14, 2026, the board of directors approved the proposal for a share incentive plan, which is subject to shareholder approval. The share incentive plan constitutes a share scheme under Chapter 17 of the Listing Rules and will therefore comply with the provisions of Chapter 17 of the Listing Rules. On August 14, 2026, the board of directors decided to make the first conditional grant of awards to one employee and one consultant under the share incentive plan.
B&K CORP-B (02396) announced that on August 14, 2026, the board of directors approved the proposed Caina Technology incentive plan, which is subject to shareholder approval. The share incentive plan constitutes a share scheme under Chapter 17 of the Listing Rules, and therefore will comply with the provisions of Chapter 17 of the Listing Rules. On August 14, 2026, the board of directors decided to grant the first conditional awards under the share incentive plan to one employee and one consultant.
Related Articles

DATANG ENVIRO (01272) intends to appoint Guan Yu as a non-executive director.

US Stock Market Move | Reddit (RDDT.US) will be included in the S&P 500 index and opened with a surge of over 13%.

YAN PALACE (01497) announced its mid-term results, with a profit attributable to shareholders of 107 million yuan, an increase of 42.72% year-on-year.
DATANG ENVIRO (01272) intends to appoint Guan Yu as a non-executive director.

US Stock Market Move | Reddit (RDDT.US) will be included in the S&P 500 index and opened with a surge of over 13%.

YAN PALACE (01497) announced its mid-term results, with a profit attributable to shareholders of 107 million yuan, an increase of 42.72% year-on-year.

RECOMMEND





